• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Federated Hermes US SMID Equity Fund Class F2 GBP Inc Hedged

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund ProviderHermes Fund Managers Ireland Ltd
Fund SummaryThe investment objective of the fund is to provide long-term capital appreciation by investing primarily in equity or equity related securities of small and mid-capitalisation companies domiciled in the US, or which derive a large proportion of their income from US activities. These are primarily listed or traded in the US or Canada.
SEDOL codeBBL4VB5
ISINIE00BBL4VB58
Fund codeHUFHI
ManagersMark Sherlock, Michael Russell
Manager Tenure8 years
Morningstar CategoryOther Equity
IMA SectorNorth American Smaller Companies
Fund Size£518 million
Fund TypeOEIC
Management StyleActive
Ongoing Charge Figure (OCF)0.92%
Cavendish ongoing charge0.05%
FundsNetwork Service Fee0.20%
Minimum Initial Investment£25
Minimum Top Up£25
Minimum Monthly Investment£25
Sell Price£1.3742
Buy Price£1.3742
Price Change+1.597%
Price Date29th September 2020
YieldCurrently unavailable
Dividend FrequencySemi-Annually
ISA EligibleYes
SIPP EligibleYes
Inception Date3rd April 2018
Fund StatusOPEN
Mark joined the US SMID team in February 2009 as co-manager of the US SMID Cap strategy and became lead manager in October 2013. He was appointed as Head of US Equities in October 2017. Mark initially joined Federated Hermes in 2005 as an analyst and fund manager on the UK Focus Fund. Prior to this, he was an investment analyst at Rio Tinto Pension Fund, where he had responsibility for the small- and mid-cap portion of the portfolio. Mark qualified as a Chartered Accountant with PricewaterhouseCoopers in 2002. He has a degree in Politics from Durham University and is a CFA charterholder.

3-year Mean Monthly Return: 0.464%

Annual Returns20192018201720162015
Fund Performance-12.31%+1.35%+8.98%+15.64%+1.41%
Benchmark Performance
(Other Equity)
Time PeriodCumulativeBenchmark Performance
(Other Equity)
Fund Compared to Benchmark
1 day1.60%Currently unavailableCurrently unavailable
1 week1.38%Currently unavailableCurrently unavailable
1 month-3.12%Currently unavailableCurrently unavailable
3 months8.09%Currently unavailableCurrently unavailable
6 months26.63%Currently unavailableCurrently unavailable
1 year-8.85%Currently unavailableCurrently unavailable
3 years0.47%Currently unavailableCurrently unavailable
5 years5.87%Currently unavailableCurrently unavailable
10 yearsCurrently unavailableCurrently unavailableCurrently unavailable
YTD-14.30%Currently unavailableCurrently unavailable
Since inception5.48%Currently unavailableCurrently unavailable

Top 10 shares for this fund

Share NameCountryValue
Abiomed IncUSA3.03%
Wintrust Financial CorpUSA2.57%
Teradyne IncUSA2.56%
Silicon Laboratories IncUSA2.47%
PTC IncUSA2.45%
Brunswick CorpUSA2.41%
Fortune Brands Home & Security IncUSA2.34%
Cubic CorpUSA2.34%
A.O. Smith CorpUSA2.24%
Brooks Automation IncUSA2.20%
Dividend DatePer share amountReinvestment Price
1st July 20200.0009£1.3183
1st July 20190.0002£1.5070
1st July 20160.0002£1.1825
31st December 20150.0001£1.1004